HemoGenyx Says CBR Platform Could Potentially Be Used for Cancer Treatment

1 year ago 43
By Christian Moess Laursen HemoGenyx Pharmaceuticals said its Chimeric Bait Receptor, or CBR, platform can potentially be used in cancer treatment, in...
Read Entire Article